The therapeutic effects of marine sulfated polysaccharides on diabetic nephropathy

被引:6
作者
Wu, Lijuan [1 ,2 ,3 ]
Zhang, Xiaonan [2 ,3 ]
Zhao, Jun [2 ,3 ]
Yang, Menglin [2 ,3 ]
Yang, Jinbo [1 ,2 ,3 ]
Qiu, Peiju [1 ,2 ,3 ]
机构
[1] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Yushan Rd, Qingdao 266003, Peoples R China
[2] Pilot Natl Lab Marine Sci & Technol Qingdao, Ctr Innovat Marine Drug Screening &Evaluat, Qingdao 266237, Peoples R China
[3] Marine Biomed Res Inst Qingdao, Qingdao 266071, Peoples R China
关键词
Marine sulfated polysaccharide; Diabetic nephropathy; Mechanisms; Structure-activity relationship; MOLECULAR-WEIGHT FUCOIDAN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLAST-GROWTH-FACTOR; P-SELECTIN; STRUCTURAL-CHARACTERIZATION; ENDOTHELIAL GLYCOCALYX; HEPARANASE; BINDING; SULODEXIDE; DISEASE;
D O I
10.1016/j.ijbiomac.2024.129269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Marine sulfated polysaccharide (MSP) is a natural high molecular polysaccharide containing sulfate groups, which widely exists in various marine organisms. The sources determine structural variabilities of MSPs which have high security and wide biological activities, such as anticoagulation, antitumor, antivirus, immune regulation, regulation of glucose and lipid metabolism, antioxidant, etc. Due to the structural similarities between MSP and endogenous heparan sulfate, a majority of studies have shown that MSP can be used to treat diabetic nephropathy (DN) in vivo and in vitro. In this paper, we reviewed the anti-DN activities, the dominant mechanisms and structure-activity relationship of MSPs in order to provide the overall scene of MSPs as a modality of treating DN.
引用
收藏
页数:12
相关论文
共 97 条
[91]   Oligo-Fucoidan Improves Diabetes-Induced Renal Fibrosis via Activation of Sirt-1, GLP-1R, and Nrf2/HO-1: An In Vitro and In Vivo Study [J].
Yu, Wen-Chun ;
Huang, Ren-Yeong ;
Chou, Tz-Chong .
NUTRIENTS, 2020, 12 (10) :1-15
[92]   Sulodexide Decreases Albuminuria and Regulates Matrix Protein Accumulation in C57BL/6 Mice with Streptozotocin-Induced Type I Diabetic Nephropathy [J].
Yung, Susan ;
Chau, Mel K. M. ;
Zhang, Qing ;
Zhang, Chen Zhu ;
Chan, Tak Mao .
PLOS ONE, 2013, 8 (01)
[93]   Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives [J].
Zahan, Md Sarwar ;
Hasan, Adeba ;
Rahman, M. D. Hasanur ;
Meem, Kamrun Nahar ;
Moni, Akhi ;
Hannan, Md Abdul ;
Uddin, Md Jamal .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 209 :2119-2129
[94]   Genetic programs of epithelial cell plasticity directed by transforming growth factor-β [J].
Zavadil, J ;
Bitzer, M ;
Liang, D ;
Yang, YC ;
Massimi, A ;
Kneitz, S ;
Piek, E ;
Böttinger, EP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6686-6691
[95]   Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis [J].
Zhao, Huajun ;
Liu, Haiying ;
Chen, Yi ;
Xin, Xianliang ;
Li, Jing ;
Hou, Yongtai ;
Zhang, Zhonghua ;
Zhang, Xiongwen ;
Me, Chengying ;
Geng, Meiyu ;
Ding, Jian .
CANCER RESEARCH, 2006, 66 (17) :8779-8787
[96]   Sulfated fucan/fucosylated chondroitin sulfate-dominated polysaccharide fraction from low-edible-value sea cucumber ameliorates type 2 diabetes in rats: New prospects for sea cucumber polysaccharide based-hypoglycemic functional food [J].
Zhu, Qiyuan ;
Lin, Lianzhu ;
Zhao, Mouming .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 159 :34-45
[97]   Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1 [J].
Zong, Chengli ;
Huang, Rongrong ;
Condac, Eduard ;
Chiu, Yulun ;
Xiao, Wenyuan ;
Li, Xiuru ;
Lu, Weigang ;
Ishihara, Mayumi ;
Wang, Shuo ;
Ramiah, Annapoorani ;
Stickney, Morgan ;
Azadi, Parastoo ;
Amster, I. Jonathan ;
Moremen, Kelley W. ;
Wang, Lianchun ;
Sharp, Joshua S. ;
Boons, Geert-Jan .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (39) :13059-13067